Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic prophylaxis for children with recurrent respiratory infections
2017-003164-13Phase 3Active
- Sponsor
- HagaZiekenhuis
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in recurrent respiratory tract infection (RRTI) comparing Co-trimoxazole prophylaxis with Placebo (2 arms). Primary endpoint: Number of days with respiratory symptoms. Started May 2018; status: active.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
recurrent respiratory tract infection (RRTI)
Beyond the preview
Go deeper on 2017-003164-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003164-13.